仙琚制药：公司产品拟中选第十一批全国药品集中采购

Company Overview - Xianju Pharmaceutical (SZ 002332) announced participation in the 11th national centralized drug procurement organized by the National Organization for Drug Procurement Office on October 27-28, 2025, with its product, Vecuronium Bromide Injection, expected to be selected for this procurement [1] Financial Performance - For the first half of 2025, Xianju Pharmaceutical's revenue composition was 99.34% from pharmaceuticals and 0.66% from other businesses [1]